EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
European Journal of Cancer2019Vol. 117, pp. 60–68
Citations Over TimeTop 10% of 2019 papers
Colin R. Lindsay, Fiona Blackhall, Alexandra Carmel, Fabiola Fernández‐Gutiérrez, Paola Gazzaniga, Harry J.M. Groen, T.J.N. Hiltermann, Matthew Krebs, Sonja Loges, Rafael López‐López, Laura Muinelo‐Romay, Klaus Pantel, Lynsey Priest, Sabine Riethdorf, Elisabetta Rossi, Leon W.M.M. Terstappen, Harriet Wikman, J.-C. Soria, Françoise Farace, Andrew G. Renehan, Caroline Dive, Benjamin Besse, Stefan Michiels
Abstract
These data confirm CTCs as an independent prognostic indicator of progression-free survival and overall survival in advanced NSCLC and also reveal some evidence of between-centre heterogeneity. CTC count improves prognostication when added to full clinicopathological predictive models.
Related Papers
- → Electrochemical biosensors for the detection of lung cancer biomarkers: A review(2019)353 cited
- → Molecular genetics of lung cancer in people who have never smoked(2008)131 cited
- → Molecular Epidemiology of Female Lung Cancer(2011)10 cited
- → [Gender-associated differences of lung cancer and mechanism].(2011)3 cited
- The Expression and Clinical Significance of Adrenomedulin in Patients with Lung Cancer(2006)